logo
episode-header-image
Jun 2021
39m 10s

Software Eating The World, Healthcare St...

The Motley Fool
About this episode

Adobe hits an all-time high on earnings. Kroger raises guidance and announces a $1B stock buyback. The Honest Company issues its first report as a public company. Homebuilder Lennar posts strong profits. And electric-truck maker Lordstown Motors needs new management. Ron Gross and Jason Moser analyze those stories, discuss value plays vs. value traps, weigh in on El Pollo Loco’s flying chickens, and share two stocks on their radar: Qorvo and GAN Limited.  Plus, Motley Fool healthcare contributor Keith Speights discusses the latest on Covid vaccines, Johnson & Johnson, and the controversy surrounding the FDA’s approval of Biogen’s treatment for Alzheimer’s.

 

Looking for official stock recommendations? Get 50% off Stock Advisor just by going to http://RadarStocks.fool.com.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Up next
Yesterday
When Rates Move, Who Wins?
Lower interest rates are more than a macro headline - for some businesses, what the Federal Reserve decides to do plays an integral role for both management and investors. Today on Motley Fool Money, analysts Emily Flippen, Jason Hall, and David Meier debate the stocks most likel ... Show More
24m 17s
Aug 25
Weight Loss. Weight Loss. Don’t Tell Me.
There are new ways to tackle weight loss, but the stocks leading the way are lagging. Today on Motley Fool Money, Rick Munarriz, with analysts Karl Thiel and Jason Hall dig into the problems with weight loss stocks. There’s also a look at some investments that can survive next mo ... Show More
24m 38s
Aug 24
Interview with Stride CEO James Rhyu: Disrupting K-12 and Beyond
Is the educational system ripe for disruption? Stride is a for-profit education company that provides online and blended education programs - programs from K-12 through career certification and training. Motley Fool CEO Tom Gardner and analyst Sanmeet Deo talk with Stride CEO Jam ... Show More
23m 1s
Recommended Episodes
Aug 2021
Disney Beats the Street and Leads the Stock Market to Record Highs, the FDA's COVID Booster Shot Authorization and Companies’ Approaches to Vaccinations, What Airbnb and DoorDash’s Results Tell Us Abo
Carl Quintanilla, Morgan Brennan and Mike Santoli led off the show with Disney, whose better-than-expected quarterly results drove the stock higher, leading the Dow and S&P 500 to new record intraday highs. The anchors reacted to what Disney CEO Bob Chapek's told CNBC about Disne ... Show More
43m 46s
Aug 2021
The Chinese Stock Rally and the Cathie Wood Effect, Mandates and the Reopening Trade After Full Approval of Pfizer's COVID Vaccine, Boeing Faces New Scrutiny, Tim Cook's Decade as CEO of Apple, and t
Carl Quintanilla, Jim Cramer and David Faber explored the reasons behind a big rally in shares of China-based companies. One of the catalysts: Cathie Wood's Ark Invest buying almost 165,000 shares of JD.com. The reopening trade very much in focus one day after the FDA fully appro ... Show More
44m 6s
Sep 2021
Understanding Evergrande, Dell’s Post-Spinoff Outlook & Flying Cars
Carl Quintanilla, Jim Cramer and David Faber discuss China’s property market crisis and the Federal Reserve's decision to keep current monetary stimulus in place for just a little bit longer. The Food and Drug Administration has authorized Pfizer and BioNTech’s Covid-19 booster s ... Show More
44m 6s
Jul 2021
Stocks Erase Losses from Monday's Sell-off, Dow Components Join the Earnings Parade, Netflix's Subscriber Growth Slowdown, United Sees Profitablilty Ahead, J&J's COVID Vaccine Under Scrutiny, and Chip
Jim Cramer and David Faber took an in-depth look at a busy day for the markets with a slew of earnings reports in the mix -- as stocks recouped all of their losses from Monday's sell-off. Dow components Coca-Cola, Johnson & Johnson and Verizon all beating analyst expectations wit ... Show More
43m 12s
Mar 2023
Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker
This week on Prof G Markets, Scott gives the inside scoop on his early investment in NJOY, which will reap 30x in returns after Altria's acquisition of the vape company goes through. He also shares his thoughts on whether or not the JetBlue/Spirit Merger should be blocked, and ta ... Show More
47m 39s
Apr 2020
Despite All the Noise, PPE Is Only 1% of 3M's Bottom Line
Karen Ubelhart, Senior Industrials analyst for Bloomberg Intelligence, on 3M and Caterpillar earnings. Ellen Wald, President of Transversal Consulting and a Bloomberg Opinion contributor, on why the oil crisis will spill over into midstream companies. Jim Paulsen, Chief Investmen ... Show More
34m 12s
May 2024
ConocoPhillips to Acquire Marathon Oil in $17 Billion Deal
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg News Anchor Alix Steel reports on ConocoPhillips agreeing to acquire Marathon Oil in an all-stock deal valuing the company at about $17 billion, extending a major buying spree among the largest player ... Show More
43m 10s
Nov 2023
Chicken-Finger Billionaire Unmasked; Health Care Woes
When fast-food chain Raising Cane’s tapped the US capital market this month, it revealed a $7.6 billion fortune held by CEO Todd Graves. Strong demand for the chicken-finger maker’s bonds highlights growing investor appetite for risky debt as the US economy appears headed for a s ... Show More
21m 33s
Jul 2023
Rite Aid dips on bankruptcy report
Rite Aid (RAD) dips amid report it's considering bankruptcy to address opioid liabilities (00:28). Berkshire Hathaway (BRK.A) (BRK.B) to buy Dominion's (D) 50% stake in Cove Point LNG in $3.3B deal (01:54). Iovance Biotherapeutics (IOVA) dips on pricing $150M offering.(02:49) Tra ... Show More
6m 51s
May 2024
Walmart's Business Mix-Shift Aids Sales, Profit
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Intelligence Senior Retail Analysts Jennifer Bartashus discusses Walmart successfully growing operating income faster than sales, a trend likely to continue in fiscal 2Q as the company reaps benefits ... Show More
36m 58s